Keywords: Australia, TGA, Sanofi Pasteur, Panvax, H1N1, influenza, Side effects

654 suspected adverse reactions to Panvax reported to Australia’s TGA in one month

Article | 24 November 2009

The Australian national immunization program with the H1N1 2009 influenza vaccine Panvax, made by French drug major Sanofi-Aventis’ Sanofi-Pasteur unit, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in